Digital healthcare company Livongo received an emergency use authorization Wednesday from the U.S. Food and Drug Administration to use their remote blood glucose meter in hospitals. The San Francisco-based company says this is good news for healthcare workers who currently have limited access to personal protective equipment (PPE) and can now monitor the blood glucose levels of diabetic patients infected with COVID-19 without needing to be physically present.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,